Nitrogen rich Ligands and their Metal Complexes AIE Bioprobe Anticovid and other Biological Applications
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The interaction of small organic ligand molecules or their metal complexes
newlinehaving greater bioactivities and reduced toxic side effects with biological macro
newlinemolecules provide one of the attractive areas of coordination chemistry and drug
newlinediscovery. Schiff base ligands are one of the most important classes of flexible and
newlineversatile polydentate ligands, show high efficiency in chelating transition metal
newlineions. Carbohydrazones, thiocarbohydrazones and diaminoguanidinedihydrazones
newlineare nitrogen-rich Schiff base ligands, which are prominent in coordination
newlinechemistry due to their structurally flexible nature, multiple donor atoms and
newlinesignificant pharmacological activity, which make them intriguing subjects of study
newlinefor the development of biologically active metal complexes with potential
newlinetherapeutic applications.
newline SARS-CoV-2 is a single-stranded RNA virus that belongs to the and#120573;-
newlinecoronavirus family, responsible for the global covid-19 pandemic that emerged in
newlinelate 2019. In silico docking study with SARS-CoV-2 is highly relevant in the quest
newlineto understand and combat the covid-19 pandemic. This approach aimed to gain
newlineinsights into the binding interactions between viral proteins and potential inhibitors,
newlinethereby aiding in the development of targeted therapeutic candidates. Studies have
newlinehighlighted the potential of bioactive Schiff bases and their complexes as promising
newlinecandidates to bind SARS-CoV-2 Mpro
newline. As various studies are progressing in several
newlinedirections to develop novel medicines for the treatment of covid-19 disease, we
newlineinitiate the possibilities of potential (thio)carbohydrazones and diaminoguanidinebased hydrazones along with their complexes as novel drug candidates against
newlineSARS-CoV-2 using in silico studies.
newline